Black Diamond Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.924; its P/E ratio is -2.73; Black Diamond Therapeutics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 334.00K	$ 334.00K	$ 335.00K	$ 135.00K	-
Gross Profit	$ 334.00K	$ 334.00K	$ 335.00K	$ 135.00K	-
EBIT	$ -19.41M	$ -23.01M	$ -19.15M	$ -20.88M	$ -21.08M
EBITDA	$ -19.32M	$ -22.89M	$ -19.04M	$ -20.75M	$ -20.42M
Net Income Common Stockholders	$ -19.41M	$ -23.01M	$ -19.15M	$ -20.88M	$ -21.08M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 131.40M	$ 144.26M	$ 89.53M	$ 103.37M	$ 122.81M
Total Assets	$ 158.57M	$ 172.38M	$ 119.88M	$ 135.58M	$ 156.25M
Total Debt	$ 22.18M	$ 23.00M	$ 23.78M	$ 24.55M	$ 25.30M
Net Debt	$ -109.22M	$ -121.26M	$ -65.75M	$ -78.82M	$ -97.51M
Total Liabilities	$ 41.83M	$ 38.06M	$ 37.68M	$ 37.39M	$ 40.56M
Stockholders Equity	$ 116.74M	$ 134.32M	$ 82.20M	$ 98.19M	$ 115.69M
Cash Flow	-
Free Cash Flow	$ -13.96M	$ -18.39M	$ -14.27M	$ 1.17M	-
Operating Cash Flow	$ -13.96M	$ -18.36M	$ -14.37M	$ 1.17M	-
Investing Cash Flow	$ 12.25M	$ -37.88M	$ 17.18M	$ 24.81M	-
Financing Cash Flow	$ -46.00K	$ 71.93M	-	$ 51.00K	-

Currency in USD

Black Diamond Therapeutics Earnings and Revenue History

Income Statement >

Black Diamond Therapeutics Debt to Assets

Balance Sheet >

Black Diamond Therapeutics Cash Flow

Cash Flow >

Black Diamond Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing